Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study-Reference-Cited by-同舟云学术

Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study

Published:2017-04-27 Issue:12 Volume:116 Page:1520-1525
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Triggiani Luca,Alongi Filippo,Buglione Michela,Detti Beatrice,Santoni Riccardo,Bruni Alessio,Maranzano Ernesto,Lohr Frank,D’Angelillo Rolando,Magli Alessandro,Bonetta Alberto,Mazzola Rosario,Pasinetti Nadia,Francolini Giulio,Ingrosso Gianluca,Trippa Fabio,Fersino Sergio,Borghetti Paolo,Ghirardelli Paolo,Magrini Stefano Maria

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc2017103.pdf

Reference20 articles.

1. Ahmed KA, Barney BM, Davis BJ, Park SS, Kwon ED, Olivier KR (2013) Stereotactic body radiation therapy in the treatment of oligometastatic prostate cancer. Front Oncol 2: 215.

2. Alongi F, Arcangeli S, Filippi AR, Ricardi U, Scorsetti M (2012) Review and uses of stereotactic body radiation therapy for oligometastases. Oncologist 17 (8): 1100–1107.

3. Beer TM, Armstrong AJ, Rathkopf DE, Loriot Y, Sternberg CN, Higano CS, Iversen P, Bhattacharya S, Carles J, Chowdhury S, Davis ID, de Bono JS, Evans CP, Fizazi K, Joshua AM, Kim CS, Kimura G, Mainwaring P, Mansbach H, Miller K, Noonberg SB, Perabo F, Phung D, Saad F, Scher HI, Taplin ME, Venner PM, Tombal B (2014) Enzalutamide in metastatic prostate cancer before chemotherapy; PREVAIL Investigators. N Engl J Med 371: 424–433.

4. Casamassima F, Masi L, Menichelli C, Bonucci I, Casamassima E, Lazzeri M, Gulisano M, Aterini S (2011) Efficacy of eradicative radiotherapy for limited nodal metastases detected with choline PET scan in prostate cancer patients. Tumori 97 (1): 49–55.

5. Cheng HH, Lin DW, Yu EY (2012) Advanced clinical states in prostate cancer. Urol Clin North Am 39: 561–571.

Cited by 132 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stereotactic ablative radiotherapy for oligoprogressive solid tumours: A systematic review and meta-analysis;Radiotherapy and Oncology;2024-11

2. Prognostic value of circulating tumor cells in oligorecurrent hormone‐sensitive prostate cancer patients undergoing stereotactic body radiation therapy;The Prostate;2024-09-06

3. A Phase II Trial of Stereotactic Body Radiation Therapy and Androgen Deprivation for Oligometastases in Prostate Cancer (SBRT-SG 05);Practical Radiation Oncology;2024-09

4. Outcomes of Radiotherapy in Oligoprogressive Breast Cancer;Journal of Personalized Medicine;2024-07-29

5. Systematic review of the efficacy of stereotactic ablative radiotherapy for oligoprogressive disease in metastatic cancer;Radiotherapy and Oncology;2024-07